- Datum07.07.2025
- Uhrzeit17:00 - 18:00 Uhr
- Veranstalter
XTB
J. Klatt
Moderator
Enanta Pharmaceuticals Inc. Aktie
Verkaufen
Kaufen
Enanta Pharmaceuticals Inc. Chart
Echtzeit-News zu diesem und anderen Unternehmen findest Du hier!
Live-Ticker Enanta Pharmaceuticals Inc. Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
-1,00 %
Intraday
4,37 %
1 Woche
5,62 %
1 Monat
37,22 %
Seit Jahresbeginn
-41,08 %
1 Jahr
-84,79 %
3 Jahre
-84,36 %
5 Jahre
-82,47 %
10 Jahre
Passender Service zu Enanta Pharmaceuticals Inc.
Webinar zu Enanta Pharmaceuticals Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)4,090-17,235
- Jahrestief / Hoch ($)4,090-8,760
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Enanta Pharmaceuticals Inc.
Keine Dividenden verfügbar
Termine von Enanta Pharmaceuticals Inc.
- Aug11Enanta Pharmaceuticals Inc.Q3 2025 Earnings Release
- Nov24Enanta Pharmaceuticals Inc.Q4 2025 Earnings Release
- Feb10Enanta Pharmaceuticals Inc.Q1 2026 Earnings Release
Beschreibung
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts.
